Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
Hingtgen TimDirector · President and COO
|
GrantStock Options (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014733 · doc4.xml · derivative · entry 3 Hingtgen Tim · CIK 0001598637 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
Hingtgen TimDirector · President and COO
|
GrantPerformance Based Restricted · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014733 · doc4.xml · derivative · entry 2 Hingtgen Tim · CIK 0001598637 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
Hingtgen TimDirector · President and COO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014733 · doc4.xml · nonDerivative · entry 1 Hingtgen Tim · CIK 0001598637 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,131 F1 · price: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
HAMMONS KEVIN JEVP and CFO
|
Disposition to issuerPerformance Based Restricted · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014731 · doc4.xml · derivative · entry 5 HAMMONS KEVIN J · CIK 0001542264 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
HAMMONS KEVIN JEVP and CFO
|
GrantStock Options (Right to Buy) · Derivative | 47,500 | $0.00 Strike: $4.93 | $0.00 |
DisclosureSEC source: 0001209191-20-014731 · doc4.xml · derivative · entry 4 HAMMONS KEVIN J · CIK 0001542264 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires 2031-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
HAMMONS KEVIN JEVP and CFO
|
GrantPerformance Based Restricted · Derivative | 95,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014731 · doc4.xml · derivative · entry 3 HAMMONS KEVIN J · CIK 0001542264 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
HAMMONS KEVIN JEVP and CFO
|
Tax withholdingCommon Stock | 6,362 | $4.93 | $31,364.66 |
DisclosureSEC source: 0001209191-20-014731 · doc4.xml · nonDerivative · entry 2 HAMMONS KEVIN J · CIK 0001542264 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,696 Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:35 UTC |
HAMMONS KEVIN JEVP and CFO
|
GrantCommon Stock | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014731 · doc4.xml · nonDerivative · entry 1 HAMMONS KEVIN J · CIK 0001542264 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,058 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · derivative · entry 8 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Based on the Reporting Peron's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of the Common Stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · derivative · entry 7 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · derivative · entry 6 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · derivative · entry 5 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,166 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · nonDerivative · entry 3 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · nonDerivative · entry 2 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
Ely James S. IIIDirector
|
Exercise / conversionCommon Stock | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014723 · doc4.xml · nonDerivative · entry 1 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · derivative · entry 7 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · derivative · entry 6 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · derivative · entry 5 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · derivative · entry 4 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,166 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · nonDerivative · entry 3 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,205 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · nonDerivative · entry 2 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:31 UTC |
CLERICO JOHN ADirector
|
Exercise / conversionCommon Stock | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014718 · doc4.xml · nonDerivative · entry 1 CLERICO JOHN A · CIK 0001219951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
DINKINS MICHAELDirector
|
GrantRestricted Stock Units · Derivative | 34,483 | $4.93 Strike: $0.00 | $170,001.19 |
DisclosureSEC source: 0001209191-20-014722 · doc4.xml · derivative · entry 5 DINKINS MICHAEL · CIK 0001123483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,483 Underlying: Common Stock · 34,483 shares Expires 2030-02-28 F1 · price: The security converts to common stock on a one-to-one basis. F2 · derivative.exercise_date: The Restricted Stock Units vest in 1/3 increments on the first, second and third anniversary date of the date of grant. Upon vesting, the Reporting Person will be issued that number of shares of the Common Stock of the Company. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
DINKINS MICHAELDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 11,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014722 · doc4.xml · derivative · entry 4 DINKINS MICHAEL · CIK 0001123483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,712 Underlying: Common Stock · 11,356 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
DINKINS MICHAELDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 12,373 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014722 · doc4.xml · derivative · entry 3 DINKINS MICHAEL · CIK 0001123483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,372 Underlying: Common Stock · 12,373 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
DINKINS MICHAELDirector
|
Exercise / conversionCommon Stock | 11,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014722 · doc4.xml · nonDerivative · entry 2 DINKINS MICHAEL · CIK 0001123483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| March 01, 2020 Filed Mar 2, 2020 23:32 UTC |
DINKINS MICHAELDirector
|
Exercise / conversionCommon Stock | 12,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014722 · doc4.xml · nonDerivative · entry 1 DINKINS MICHAEL · CIK 0001123483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The security converts to common stock on a one-to-one basis. Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:18 UTC |
Krishnan K RangaDirector
|
GrantStock Units (SU) · Derivative | 10,344.828 | $2.90 Strike: $0.00 | $30,000.00 |
DisclosureSEC source: 0001209191-20-000289 · doc4.xml · derivative · entry 2 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,957.011 Underlying: Common Stock · 10,344.828 shares Expires not disclosed F1 · derivative.exercise_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. F1 · derivative.expiration_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| December 07, 2019 Filed Dec 9, 2019 21:23 UTC |
Aaron Thomas JEVP and CFO
|
Tax withholdingCommon Stock | 26,372 | $3.62 | $95,466.64 |
DisclosureSEC source: 0001209191-19-059650 · doc4.xml · nonDerivative · entry 1 Aaron Thomas J · CIK 0001705224 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,515 Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:17 UTC |
Hingtgen TimDirector · President and COO
|
Tax withholdingCommon Stock | 6,559 | $3.73 | $24,465.07 |
DisclosureSEC source: 0001209191-19-051657 · doc4.xml · nonDerivative · entry 1 Hingtgen Tim · CIK 0001598637 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,131 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 20:18 UTC |
Krishnan K RangaDirector
|
GrantStock Units (SU) · Derivative | 8,333.333 | $3.60 Strike: $0.00 | $30,000.00 |
DisclosureSEC source: 0001209191-19-051282 · doc4.xml · derivative · entry 2 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,612.183 Underlying: Common Stock · 8,333.333 shares Expires not disclosed F1 · derivative.exercise_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. F1 · derivative.expiration_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| August 29, 2019 Filed Aug 29, 2019 20:59 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 215,150 | $2.18 | $468,596.70 |
DisclosureSEC source: 0001209191-19-047723 · doc4.xml · nonDerivative · entry 3 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,836,482 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/29/2019 at prices ranging from $2.12 to $2.20, inclusive. Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 20:59 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 489,250 | $2.05 | $1,001,984.00 |
DisclosureSEC source: 0001209191-19-047723 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,621,332 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/28/2019 at prices ranging from $1.87 to $2.14, inclusive. Read SEC document |
| August 27, 2019 Filed Aug 27, 2019 20:15 UTC |
Fordham Benjamin CEVP and General Counsel
|
PurchaseCommon Stock | 25,000 | $1.85 | $46,300.00 |
DisclosureSEC source: 0001209191-19-047497 · doc4.xml · nonDerivative · entry 1 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,416 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/27/2019 at prices ranging from $1.825 to $1.865, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 27, 2019 Filed Aug 29, 2019 20:59 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 495,600 | $1.84 | $911,904.00 |
DisclosureSEC source: 0001209191-19-047723 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,132,082 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 8/27/2019 at prices ranging from $1.80 to $1.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1), (2) and (3) of this Form 4. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 20:23 UTC |
Fordham Benjamin CEVP and General Counsel
|
PurchaseCommon Stock | 25,000 | $2.29 | $57,250.00 |
DisclosureSEC source: 0001209191-19-045104 · doc4.xml · nonDerivative · entry 1 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,416 F1 · price: These shares were purchased in a series of transactions at a weighted average purchase price of approximately $2.29 per share. Read SEC document |
| June 30, 2019 Filed Jul 1, 2019 20:22 UTC |
Krishnan K RangaDirector
|
GrantStock Units (SU) · Derivative | 11,235.955 | $2.67 Strike: $0.00 | $30,000.00 |
DisclosureSEC source: 0001209191-19-039710 · doc4.xml · derivative · entry 2 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,278.85 Underlying: Common Stock · 11,235.955 shares Expires not disclosed F1 · derivative.exercise_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. F1 · derivative.expiration_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 20:21 UTC |
HAMMONS KEVIN JSVP, Asst CFO, CAO & Treasurer
|
Tax withholdingCommon Stock | 2,624 | $2.66 | $6,979.84 |
DisclosureSEC source: 0001209191-19-033908 · doc4.xml · nonDerivative · entry 1 HAMMONS KEVIN J · CIK 0001542264 · SVP, Asst CFO, CAO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,558 Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 20:20 UTC |
Fordham Benjamin CEVP and General Counsel
|
Tax withholdingCommon Stock | 2,624 | $2.66 | $6,979.84 |
DisclosureSEC source: 0001209191-19-033906 · doc4.xml · nonDerivative · entry 1 Fordham Benjamin C · CIK 0001700942 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,416 Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 20:19 UTC |
Aaron Thomas JEVP and CFO
|
Tax withholdingCommon Stock | 2,624 | $2.66 | $6,979.84 |
DisclosureSEC source: 0001209191-19-033901 · doc4.xml · nonDerivative · entry 1 Aaron Thomas J · CIK 0001705224 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,887 Read SEC document |
| May 28, 2019 Filed May 29, 2019 20:16 UTC |
DINKINS MICHAELDirector
|
PurchaseCommon Stock | 4,000 | $3.17 | $12,672.00 |
DisclosureSEC source: 0001209191-19-033179 · doc4.xml · nonDerivative · entry 1 DINKINS MICHAEL · CIK 0001123483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,028 Read SEC document |
| May 20, 2019 Filed May 20, 2019 20:20 UTC |
Ely James S. IIIDirector
|
PurchaseCommon Stock | 50,000 | $3.15 | $157,500.00 |
DisclosureSEC source: 0001209191-19-031370 · doc4.xml · nonDerivative · entry 2 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,320 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/20/2019 at prices ranging from $3.145 to $3.150, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:20 UTC |
Ely James S. IIIDirector
|
PurchaseCommon Stock | 50,000 | $3.25 | $162,500.00 |
DisclosureSEC source: 0001209191-19-031370 · doc4.xml · nonDerivative · entry 1 Ely James S. III · CIK 0001463791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,320 Read SEC document |
| May 08, 2019 Filed May 8, 2019 20:20 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 6,551 | $3.47 | $22,718.87 |
DisclosureSEC source: 0001209191-19-028227 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,636,482 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/8/2019 at prices ranging from $3.36 to $3.575, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Together with shares purchased by the reporting person on 5/3/2019, 5/6/2019 and 5/7/2019, which purchases were reported in the Form 4 filed for the reporting person on 5/7/2019, the reporting person has purchased a total of 1,000,000 shares of the Issuer's common stock since 5/3/2019 at a weighted average purchase price for all such purchases of $3.368. Read SEC document |
| May 07, 2019 Filed May 7, 2019 21:45 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 178,893 | $3.28 | $587,126.83 |
DisclosureSEC source: 0001209191-19-028031 · doc4.xml · nonDerivative · entry 3 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629,931 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/7/2019 at prices ranging from $3.125 to $3.51, inclusive. Read SEC document |
| May 06, 2019 Filed May 7, 2019 21:45 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 491,472 | $3.43 | $1,685,748.96 |
DisclosureSEC source: 0001209191-19-028031 · doc4.xml · nonDerivative · entry 2 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,451,038 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/6/2019 at prices ranging from $3.29 to $3.50, inclusive. Read SEC document |
| May 03, 2019 Filed May 7, 2019 21:45 UTC |
SMITH WAYNE TDirector · Chairman & CEO
|
PurchaseCommon Stock | 323,084 | $3.32 | $1,072,315.80 |
DisclosureSEC source: 0001209191-19-028031 · doc4.xml · nonDerivative · entry 1 SMITH WAYNE T · CIK 0001018660 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959,566 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on 5/3/2019 at prices ranging from $3.225 to $3.40, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| March 31, 2019 Filed Apr 1, 2019 20:15 UTC |
Krishnan K RangaDirector
|
GrantStock Units (SU) · Derivative | 8,042.895 | $3.73 Strike: $0.00 | $30,000.00 |
DisclosureSEC source: 0001209191-19-021966 · doc4.xml · derivative · entry 2 Krishnan K Ranga · CIK 0001724829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,042.895 Underlying: Common Stock · 8,042.895 shares Expires not disclosed F1 · derivative.exercise_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and will be settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. F1 · derivative.expiration_date: The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and will be settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:20 UTC |
Ramsey BerylDivision President
|
GrantStock Options (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001209191-19-015589 · doc4.xml · derivative · entry 4 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2029-02-28 F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:20 UTC |
Ramsey BerylDivision President
|
GrantPerformance Based Restricted · Derivative | 45,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015589 · doc4.xml · derivative · entry 3 Ramsey Beryl · CIK 0001730465 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.